Arcutis Announces Second Quarter 2025 Financial Results and Provides Business Update
Provided By GlobeNewswire
Last update: Aug 6, 2025
WESTLAKE VILLAGE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported financial results for the quarter ended June 30, 2025, and provided a business update.
Read more at globenewswire.comNASDAQ:ARQT (11/5/2025, 10:42:46 AM)
24.07
+0.06 (+0.25%)
Find more stocks in the Stock Screener
ARQT Latest News and Analysis
8 days ago - By: Chartmill
